Press Release RECKITT ANNOUNCES U.S. FDA APPROVAL OF MUCINEX® 12HR COLD & FEVER MULTI-SYMPTOM, THE FIRST OTC INNOVATION IN THE COLD & FLU CATEGORY IN 14 YEARS Aug 5
Press Release Reckitt Announces Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044 Aug 5